Rocatinlimab, administered subcutaneously, results in clinically meaningful improvements in patients with moderate-to-severe atopic dermatitis, with an acceptable safety profile.

At any given moment in time, more than 400 million individuals worldwide are battling depression. The antidepressant ...

When neurologist Steven Arnold is deciding whether to treat an Alzheimer's patient with a new therapy, he relies on averages.

Recent clinical research indicates that semaglutide may effectively reverse weight gain and blood sugar issues caused by ...

Background Intensive blood pressure (BP) control <130/80 mm Hg could bring additional benefits for cardiovascular disease ...

TXA is an inexpensive (approximately $3 per gram) and widely available antifibrinolytic medication with an established safety ...

Writing in JAMA, regulators said randomized controlled trials with a survival or time-to-event endpoint would be expected for approval of a new CAR T-cell therapy.

The complete response or better rate was 81.1% with the combination versus 31.1% in the control arm, while patients treated ...

A low-protein diet, defined as 0.6 g/kg/day, is recommended for CKD patients, contrasting with the higher average intake in ...

Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...

A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or ...